tiprankstipranks
Trending News
More News >
Evgen Pharma (GB:TCF)
:TCF
UK Market
Advertisement

Evgen Pharma (TCF) Technical Analysis

Compare
4 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Evgen Pharma’s (TCF) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Evgen Pharma is a Buy.
Evgen Pharma’s (TCF) 20-Day exponential moving average is 0.21, while Evgen Pharma’s (TCF) share price is 0.21p, making it a Sell.
Evgen Pharma’s (TCF) 50-Day exponential moving average is 0.22, while Evgen Pharma’s (TCF) share price is 0.21p, making it a Sell.

Evgen Pharma (TCF) Pivot Points

Nov 24, 2025, 02:36 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.15
0.17
0.18
0.20
0.21
0.23
0.24
Fibonacci
0.17
0.18
0.19
0.20
0.21
0.22
0.23
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Evgen Pharma (TCF) Moving Averages

Nov 24, 2025, 02:36 PM
Period
Simple
Exponential
MA5
0.20Sell
0.20Sell
MA10
0.21Sell
0.20Sell
MA20
0.21Sell
0.21Sell
MA50
0.22Sell
0.22Sell
MA100
0.23Sell
0.24Sell
MA200
0.26Sell
0.32Sell
Evgen Pharma’s (TCF) 10-Day exponential moving average is 0.20, while Evgen Pharma’s (TCF) share price is 0.21p, making it a Sell.
Evgen Pharma’s (TCF) 100-Day exponential moving average is 0.24, while Evgen Pharma’s (TCF) share price is 0.21p, making it a Sell.
Evgen Pharma’s (TCF) stock price is 0.21p and Evgen Pharma’s (TCF) 50-day simple moving average is 0.22, creating a Sell signal.
Evgen Pharma’s (TCF) stock price is 0.21p and Evgen Pharma’s (TCF) 100-day simple moving average is 0.23, creating a Sell signal.
Evgen Pharma’s (TCF) stock price is 0.21p and Evgen Pharma’s (TCF) 200-day simple moving average is 0.26, creating a Sell signal.

Evgen Pharma (TCF) Technical Indicators

Nov 24, 2025, 02:36 PM
Name
Value
Implied Action
RSI (14)
9.68
Buy
STOCH (9,6)
27.08
Neutral
STOCHRSI (14)
29.86
Neutral
MACD (12,26)
>-0.01
Buy
ADX (14)
17.54
Buy
Williams %R
-75.00
Buy
CCI (14)
-317.03
Buy
ATR (14)
0.02
-
Ultimate Oscillator
55.51
Neutral
ROC
-9.52
Sell
Evgen Pharma’s (TCF) Relative Strength Index (RSI) is 9.68, creating a Buy signal.
Evgen Pharma’s (TCF) Trend Strength Indicator (ADX) is 17.54, creating a Buy signal.
Evgen Pharma’s (TCF) Commodity Channel Index (CCI) is -317.03, creating a Buy signal.
Evgen Pharma’s (TCF) Price Rate of Change (ROC) is -9.52, creating a Sell signal.

FAQ

Is TCF a Buy, Hold, or Sell?
Based on TCF’s technical indicators, TCF is a Sell.
    What is TCF’s RSI (14)?
    TCF’s RSI (14) is 9.68, which suggests TCF is a Buy.
      What is TCF’s MACD?
      TCF’s MACD is >-0.01, which suggests TCF is a Buy.
        What is TCF’s 5-day moving average?
        TCF’s 5-day moving average is 0.20, which suggests TCF is a Sell.
          What is TCF’s 20-day moving average?
          TCF 20-day moving average is 0.21, which suggests TCF is a Sell.
            What is TCF’s 50-day moving average?
            TCF’s 50-day moving average is 0.22, which suggests TCF is a Sell.
              What is TCF’s 200-day moving average?
              TCF’s 200-day moving average is 0.26, which suggests TCF is a Sell.
                What is TCF’s Williams % R (14)?
                TCF’s Williams % R (14) is -75.00, which suggests TCF is a Buy.
                  What is TCF’s CCI (14)?
                  TCF’s CCI (14) is -317.03, which suggests TCF is a Buy.
                    What is the share price of Evgen Pharma?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis